SP092A 2-YEAR STUDY ON THE COMBINATION THERAPY OF ANGIOTENSIN II RECEPTOR BLOCKER AND MIDODRINE FOR PROTEINURIA REDUCTION IN PATIENTS WITH HYPOTENSION OR NORMAL BLOOD PRESSURE